Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Afatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 52 Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 12 Lung Neoplasms 10 Head and Neck Neoplasms 10 Breast Neoplasms 10 Neoplasm Metastasis 8 Carcinoma, Squamous Cell 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Prostatic Neoplasms 3 Glioblastoma 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Solid Tumors 2 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thoracic Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Cancers of the Head and Neck 1 Small Cell Lung Carcinoma 1

Interventions

Etoposide 130 Carboplatin 115 Cisplatin 85 Topotecan 64 durvalumab 47 atezolizumab 41 Irinotecan 39 pembrolizumab 30 Paclitaxel 28 Radiotherapy 27 Nivolumab 27 PM 01183 21 Drug Therapy 19 apatinib 18 anlotinib 17 Platinum 16 Ipilimumab 15 Gemcitabine 15 olaparib 13 Radiosurgery 13 Docetaxel 13 Bevacizumab 12 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 toripalimab 10 rovalpituzumab tesirine 10 tislelizumab 9 amrubicin 9 Temozolomide 9 Specimen Handling 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02876081 2017-09-11

THEN

Fondation Hôpital Saint-Joseph

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡